News

Boston Pharmaceuticals Appoints Joanne Beck, Ph.D., as Chief Operating Officer Joanne Beck, Ph.D., Chief Operating Officer (Photo: Business Wire) December 19, 2019 08:00 AM Eastern Standard Time ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Boston Pharmaceuticals Inc. (Boston Pharmaceuticals) today announced that it has in-licensed a portfolio of five early development programs from GlaxoSmithKline ...
New drug developer Boston Pharmaceuticals has secured a $600 million commitment from Gurnet Point Capital. In addition to the financing, Christopher Viehbacher, a managing partner of Gurnet Point ...
CAMBRIDGE, Mass., April 23, 2025--Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, an investigational, once-monthly FGF21 analogue for the treatment ...
RELATED: Boston Pharmaceuticals bags 8 assets in back-to-back deals with GlaxoSmithKline and Novartis “Through our relationship with Boston Pharmaceuticals, we can explore more mechanisms of ...
Boston Pharmaceuticals is launching with $600 million. Led by the former CEO of Sanofi, the company's focused on developing drugs ready to enter the clinic.
The ICR team used a drug from Boston Pharmaceuticals called BOS172722 to cause cancer cells to divide too rapidly. When combined with paclitaxel in lab dishes, all cancer cells died, while 40% of ...
Boston Scientific To Sell BTG Specialty Pharmaceuticals Business In $800 Mln Cash Deal - Quick Facts RTTNews Dec. 1, 2020, 06:40 AM ...
The positions in the table below reflect the Boston Pharmaceuticals's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...
BOSTON, June 9, 2025 – The Renaissance Boston Seaport District recently debuted its stunning new rooms… Scouting America is proud to announce that Bob Rivers, Executive Chair and Chair of the ...
Boston Pharmaceuticals today announces the appointment of Joanne Beck, Ph.D., as Chief Operating Officer. Dr. Beck joins Boston Pharmaceuticals from Celgene Corporation, where she was Executive ...